Variables | n = 95b | Median cost (Q1-Q3) | 95% CI |
---|---|---|---|
Age | Â | Â | Â |
  ≤ 4 | 18 | 2.6 (1.0-11.5) | 0.0-6.5 |
  ≥ 5 | 77 | 8.9 (2.5-18.3) | 6.0-11.7 |
Sex | Â | Â | Â |
  Male | 39 | 8.7 (1.7-21.5) | 3.6-13.7 |
  Female | 56 | 6.5 (2.4-14.3) | 4.0-9.0 |
First therapeutic option | Â | Â | Â |
  Informal | 57 | 5.7 (1.3-13.5) | 2.5-8.8 |
  Formal | 38 | 8.9 (1.8-19.4) | 5.2-12.6 |
Number of therapeutic options used | Â | Â | Â |
  1 | 58 | 3.3 (1.7-13.3) | 0.0-11.6 |
  2 | 32 | 7.4 (1.7-23.4) | 2.3-12.6 |
  3 | 5 | 8.8 (2.5-15.0) | 6.2-11.4 |
Health problems | Â | Â | Â |
  Malaria syndrome | 31 | 3.9 (1.0-15.8) | 1.1-6.7 |
  Respiratory tract syndrome | 23 | 8.9 (2.7-13.7) | 6.0-11.8 |
  WHS complex | 15 | 10.7 (3.5-26.9) | 3.4-17.9 |
  Others | 26 | 7.5 (2.0-14.7) | 4.8-10.2 |
Level of education of household head | Â | Â | Â |
  Illiterate and primary education | 22 | 11.3 (2.6-18.8) | 5.8-16.7 |
  Secondary education | 48 | 5.3 (1.1-17.1) | 1.6-8.9 |
  Higher education | 25 | 9.8 (3.3-15.6) | 5.9-13.6 |
Socioeconomic status of the household | Â | Â | Â |
  1 (Poorest) | 20 | 8.8 (4.6-15.4) | 5.0-12.6 |
  2 | 23 | 9.4 (1.7-24.6) | 1.9-17.0 |
  3 | 17 | 6.1 (1.7-36.1) | 0.0-19.3 |
  4 | 20 | 8.2 (2.6-15.1) | 3.8-12.7 |
  5 (Richest) | 15 | 4.9 (1.7-11.6) | 0.9-8.9 |